Evaluation of mRNA biomarkers to identify risk of hospital acquired infections in children admitted to paediatric intensive care unit

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Peronnet, Estelle ^a   Nguyen, Kha ^b   Cerrato, Elisabeth ^a   Guhadasan, Rathi ^b   Venet, Fabienne ^a   Textoris, Julien ^a   Pachot, Alexandre ^a   Monneret, Guillaume ^a   Carrol, Enitan Delphine ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 PROTEIN, HUMAN; BID PROTEIN, HUMAN; BIOLOGICAL MARKER; CD3 ANTIGEN; CYTOKINE; IL10 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BID;

ADOLESCENT; CHILD; CHROMOSOME ABERRATION; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; INFANT; INFLAMMATION; LENGTH OF STAY; MALE; METABOLISM; MICROBIOLOGY; NEWBORN; PEDIATRIC INTENSIVE CARE UNIT; PRESCHOOL CHILD; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ANTIGENS, CD3; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; INTENSIVE CARE UNITS, PEDIATRIC; INTERLEUKIN-10; INTERLEUKIN-1BETA; LENGTH OF STAY; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; QUALITY CONTROL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 85011881838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152388     Document Type: Article

References (40)

1. Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohé J, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med. 2010; 36: 1859–1866. doi: 10.1007/s00134-010-1962-x PMID: 20652682
2. Lukaszewicz A-C, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009; 37: 2746–2752. doi: 10.1097/CCM.0b013e3181ab858a PMID: 19707128 mRNA Biomarkers to Predict Hospital Acquired Infections
3. Kumpf O, Schumann RR. Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: evidence from human studies and animal models. J Innate Immun. 2010; 2: 381–394. doi: 10.1159/000314269 PMID: 20431282
4. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006; 6: 813–822. doi: 10.1038/nri1943 PMID: 17039247
5. Weber SU, Schewe J-C, Lehmann LE, Müller S, Book M, Klaschik S, et al. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care. 2008; 12: R128. doi: 10. 1186/cc7088 PMID: 18925930
6. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Hui JJ, Chang KC, et al. Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans. J Immunol. 2001; 166: 6952–6963. PMID: 11359857
7. Venet F, Lukaszewicz A-C, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. 2013; 25: 477–483. doi: 10.1016/j.coi.2013.05.006 PMID: 23725873
8. Getting ahead of the curve: A strategy for combating infectious disease [Internet]. Available: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/Browsable/DH_4985689
9. Epidemiology data on healthcare associated infections. Available: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/HCAI/EpidemiologicalDataHCAI/
10. Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care. 2011; 15: R99. doi: 10.1186/cc10112 PMID: 21418617
11. Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care Lond Engl. 2010; 14: R133. doi: 10.1186/ cc9181
12. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard A-L, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006; 32: 1175–1183. doi: 10.1007/s00134-006-0204-8 PMID: 16741700
13. Monneret G, Finck M-E, Venet F, Debard A-L, Bohé J, Bienvenu J, et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett. 2004; 95: 193–198. doi: 10.1016/j.imlet.2004.07.009 PMID: 15388260
14. Tissières P, Ochoda A, Dunn-Siegrist I, Drifte G, Morales M, Pfister R, et al. Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. PloS One. 2012; 7: e32863. doi: 10. 1371/journal.pone.0032863 PMID: 22427899
15. CDC/NHSN Surveillance Definitions for Specific Types of Infections. 2014. Available: http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf
16. Carrol ED, Salway F, Pepper SD, Saunders E, Mankhambo LA, Ollier WE, et al. Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol. 2007; 8: 20. doi: 10.1186/1471-2172-8-20 PMID: 17850649
17. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007; 8: R19. PMID: 17291332
18. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303–1310. PMID: 11445675
19. Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg. 2010; 252: 1065–1071. doi: 10.1097/SLA.0b013e3181dcf36e PMID: 20571363
20. Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, et al. Global Epidemiology of Pediatric Severe Sepsis: the Sepsis PRevalence, OUtcomes, and Therapies Study. Am J Respir Crit Care Med. 2015; doi: 10.1164/rccm.201412-2323OC
21. Girardin E, Grau GE, Dayer J-M, Roux-Lombard P, Lambert P-H. Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura. N Engl J Med. 1988; 319: 397–400. doi: 10.1056/NEJM198808183190703 PMID: 3135497
22. Waage A, Espevik T, Lamvik J. Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand J Immunol. 1986; 24: 739–743. PMID: 3798026
23. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011; 29: 71–109. doi: 10.1146/annurev-immunol-031210-101312 PMID: 21166540
24. Bell MJ, Kochanek PM, Doughty LA, Carcillo JA, Adelson PD, Clark RS, et al. Comparison of the interleukin-6 and interleukin-10 response in children after severe traumatic brain injury or septic shock. Acta Neurochir Suppl. 1997; 70: 96–97. PMID: 9416290
25. Sikora JP, Kuzański W, Andrzejewska E. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children. Med Sci Monit Int Med J Exp Clin Res. 2009; 15: CR26–31.
26. Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med. 2006; 34: 2658–2665. doi: 10.1097/01.CCM.0000240243.28129.36 PMID: 16932228
27. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma. 1996; 40: 613–616; discussion 616–617. PMID: 8614042
28. Umberger R, Thompson CL, Cashion AK, Kuhl D, Wan J, Yates CR, et al. Exaggerated plasma Interleukin 6, Interleukin 10, and Subsequent Development of Health Care-Associated Infections in Patients With Sepsis. Dimens Crit Care Nurs DCCN. 2015; 34: 100–111. doi: 10.1097/DCC. 0000000000000098 PMID: 25650495
29. Hinrichs C, Kotsch K, Buchwald S, Habicher M, Saak N, Gerlach H, et al. Perioperative Gene Expression Analysis for Prediction of Postoperative Sepsis. Clin Chem. 2010; 56: 613–622. doi: 10.1373/ clinchem.2009.133876 PMID: 20133891
30. de Saint Basile G, Geissmann F, Flori E, Uring-Lambert B, Soudais C, Cavazzana-Calvo M, et al. Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest. 2004; 114: 1512–1517. doi: 10.1172/JCI22588 PMID: 15546002
31. Almansa R, Heredia-Rodríguez M, Gomez-Sanchez E, Andaluz-Ojeda D, Iglesias V, Rico L, et al. Transcriptomic correlates of organ failure extent in sepsis. J Infect. 2014; doi: 10.1016/j.jinf.2014.12.010
32. Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014; 42: 383–391. doi: 10.1097/SHK. 0000000000000234 PMID: 25051284
33. Heffernan DS, Monaghan SF, Thakkar RK, Machan JT, Cioffi WG, Ayala A. Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care. 2012; 16: R12. doi: 10.1186/cc11157 PMID: 22264310
34. Dauwalder O, Venet F, Javouhey E, Badiou C, Gillet Y, Guignant C, et al. Assessment of cellular immune parameters in paediatric toxic shock syndrome: a report of five cases. FEMS Immunol Med Microbiol. 2012; 66: 116–119. doi: 10.1111/j.1574-695X.2012.00990.x PMID: 22587469
35. Felmet KA, Hall MW, Clark RSB, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol. 2005; 174: 3765–3772. PMID: 15749917
36. Fontaine M, Pachot A, Larue A, Mougin B, Landelle C, Venet F, et al. Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock. Crit Care Med. 2011; 39: 2684–2690. doi: 10.1097/CCM.0b013e3182282a40 PMID: 21765347
37. Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011; 37: 525–532. doi: 10.1007/s00134-010-2088-x PMID: 21153402
38. Gouel-Chéron A, Allaouchiche B, Guignant C, Davin F, Floccard B, Monneret G. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PloS One. 2012; 7: e33095. doi: 10.1371/journal.pone.0033095 PMID: 22431998
39. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013; 13: 260–268. doi: 10.1016/S1473-3099 (13)70001-X PMID: 23427891
40. Muszynski JA, Nofziger R, Greathouse K, Steele L, Hanson-Huber L, Nateri J, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care. 2014; 18: R145. doi: 10.1186/cc13980 PMID: 25005517